John G F Cleland, Philip A Kalra, Pierpaolo Pellicori, Fraser J Graham, Paul W X Foley, Iain B Squire, Peter J Cowburn, Alison Seed, Andrew L Clark, Ben Szwejkowski, Prithwish Banerjee, Justin Cooke, Mark Francis, Piers Clifford, Aaron Wong, Colin Petrie, John J V McMurray, Elizabeth A Thomson, Kirsty Wetherall, Michele Robertson, Ian Ford, Paul R Kalra
BACKGROUND AND AIMS: What is the relationship between blood tests for iron deficiency, including anaemia, and the response to intravenous iron in patients with heart failure? METHODS: In the IRONMAN trial, 1137 patients with heart failure, ejection fraction ≤ 45%, and either serum ferritin < 100 µg/L or transferrin saturation (TSAT) < 20% were randomized to intravenous ferric derisomaltose (FDI) or usual care. Relationships were investigated between baseline anaemia severity, ferritin and TSAT, to changes in haemoglobin from baseline to 4 months, Minnesota Living with Heart Failure (MLwHF) score and 6-minute walk distance achieved at 4 months, and clinical events, including heart failure hospitalization (recurrent) or cardiovascular death...
March 6, 2024: European Heart Journal